With Merck’s COVID Antiviral Announcement, Can the Pharma Pipeline Build Treatment Momentum?

 

At the start of the month, pharmaceutical company Merck dropped big news: It has developed a COVID antiviral drug that would cut hospitalization and mortality risks by 50%. In the drug’s study, patients taking the placebo pill saw 14% hospitalization rate and eight deaths, while the trial group with Merck’s drug had only 7% hospitalized and zero deaths.

This appears to be just the tip of the iceberg; Kaiser Health News reports at least three COVID antiviral candidates, including Merck’s, going through late-stage clinical trials, meaning a variety of COVID drugs could be on patient’s prescriptions here soon. What’ll be some of the positive domino effects to come from approval of COVID antivirals, not only on the pharmaceutical production pipeline, but on the general population’s health? Ira Leiderman, managing director of the healthcare practice at Cassel Salpeter & Co., gave MarketScale his take on the coming treatments.

Follow us on social media for the latest updates in B2B!

Image

Latest

farm
The Business Case for AgTech: Better Data Is Key to Managing Risk on the Farm
April 23, 2026

Farming is under more pressure than it’s been in years. Costs are rising, prices are unpredictable, and every decision carries more weight than it used to. What many still think of as a traditional industry is quietly evolving, with more farmers turning to digital tools to manage risk and stay competitive. It’s not about chasing…

Read More
pre-clinical
From Classroom to Clinic: Pre-Clinical Talent Steps Into Healthcare’s Hard-to-Fill Roles
April 23, 2026

Healthcare systems are facing a workforce crisis that’s no longer temporary—it’s structural. Even before COVID-19, staffing shortages across nursing, technical, and administrative roles were already straining capacity; today, those gaps are wider, costlier, and directly impacting patient access. With labor shortages persisting and burnout rising, health systems are being forced to rethink not just…

Read More
learning
If Higher Ed Wants Experiential Learning at Scale, It Needs a Broader Playbook
April 21, 2026

The ground is shifting under higher education. AI is changing how people learn almost overnight—and at the same time, more than half of graduates are underemployed after finishing their degrees. That’s forcing a more uncomfortable question into the open: what is a college credential really worth today? As employers and governments shift their focus…

Read More
skilled trades mentorship
Why the Modern Data Center Is Forcing Communities and Policymakers to Rethink Infrastructure
April 21, 2026

Data centers have moved from largely invisible digital infrastructure to a highly visible source of public debate as artificial intelligence accelerates demand for power, fiber, and compute capacity. The modern data center is now being built closer to population centers to support low-latency services, bringing critical infrastructure into direct contact with residential communities for…

Read More